<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dopamine agonist drugs lower serum prolactin concentrations in lactotroph adenoma (prolactinoma)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dopamine agonist drugs lower serum prolactin concentrations in lactotroph adenoma (prolactinoma)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Dopamine agonist drugs lower serum prolactin concentrations in lactotroph adenoma (prolactinoma)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Serum prolactin concentrations in females with hyperprolactinemic amenorrhea treated with bromocriptine and cabergoline. Both drugs lowered serum prolactin concentrations into the normal range (upper limit of normal equals 20 mcg/L).</div><div class="graphic_reference">Data from: Webster J, Piscitelli MD, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 1994; 331:904.</div><div id="graphicVersion">Graphic 72539 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
